Lords Bill proposes animal research labelling for medicines


A new bill being introduced in the UK House of Lords proposes to make it mandatory for medicine labels to declare when animal research has been used in their development. The bill aims to emphasise that animal research is an essential part of producing safe and effective medicines, says its sponsor, Robert Winston.

‘I wouldn’t put it any weaker than “essential”,’ Winston tells Chemistry World. ‘I don’t think that it can be replaced, in fact I think we’re going to need more animal research in the future,’ he says, adding that while efforts to reduce, refine and replace animal experiments are making progress, our understanding of the complex systems of human biology simply isn’t up to the task yet.

Robert Winston © Vladislav Galgonek/Czech News Agency/Press Association Images

‘I want to ensure that there is openness and transparency about the nature of animal research,’ Winston continues. ‘So many people think that it’s being done for trivial reasons. I want to demonstrate that it’s being done for really important reasons, and that without it we can’t progress the medical treatments that we do.’

The Association of the British Pharmaceutical Industry supports efforts by the life science sciences sector to improve openness and transparency on animal research, it said in a statement. However, it also cautions that ‘it is essential that any modifications proposed to medicinal labelling do not inadvertently discourage patients from taking the medicines which they have been prescribed’.

For Winston, the assertion that labelling might discourage people from taking their medicine is unconvincing. ‘I don’t know what the evidence for it is,’ he says. ‘People have to make their own choices – for example, are you going to refuse to give your child an antibiotic because it’s been tested on animals? I would argue that that would be irresponsible. But it’s also irresponsible not to tell people that it has been tested on animals,’ he says.

The bill is now at its second reading in the House of Lords. After that, it will go before a committee of the House, where amendments may be made to ensure it the bill is appropriate and workable. This is also where details such as the timing of when the bill and associated penalties will be sorted out, and appropriate stakeholders consulted. Once it has assent from the Lords, it must also be passed in the House of Commons, so it is likely to be some time before it passes into law, if at all.


Related Content

Pushing the boundaries

28 January 2009 Premium contentFeature

news image

One drug can be useful for many different conditions - some of which it isn't licensed for. Peter Mitchell finds out how far ...

Animal pharm

30 July 2013 Feature

news image

Making drugs to treat animals is potentially lucrative – but also difficult, as Clare Sansom discovers

Most Read

Higher levels of some metals in e-cigarette smoke

8 September 2014 Research

news image

Scientists call for regulators to help clear smoke and mirrors surrounding vaping safety

Isotope effect produces new type of chemical bond

22 October 2014 Research

news image

Evidence emerges for vibrational bond first proposed 30 years ago

Most Commented

Indian U-turn on diabetes drug ban

16 August 2013 News and Analysis

news image

Suspension of cheap and popular medicine reversed but will now come with new safety warnings

DNA waves don't wash

10 July 2013 The Crucible

news image

Philip Ball asks why a spectacular claim seems to have been overlooked. Sometimes science doesn’t work the way it’s suppo...